Flagship Biosciences Inc. services

Empowering better decisions through unique, cell-based tissue analysis. Flagship’s pathologist-driven image analysis generates unique cellular data profiles that allow for flexible yet robust quantitative solutions. With one of the largest tissue image analysis operations in the world, we provide contextual biomarker data services powered by proprietary image analysis technology. Our patented, cell-based tissue analysis delivers high-complexity, data-rich tissue interpretations that remove the inherent variability of subjective manual scoring.

Expertise in pathology, biology, image analysis, data science, artificial intelligence and assay development. What does your tissue data mean for your development program? What are the next steps in using a tissue data solution for your clinical trial? How do you move forward with a patient selection strategy? Flagship’s team of experts will work with you every step of the way to ensure that you are not only receiving the right data but that you also know what that data means for your biomarker development program and clinical trial.

Whole exome sequencing, RNA sequencing, and proprietary NGS panels.

Spatial genomics and transcriptomics using highly multiplexed profiling techniques.

Data science customized for your project. Flagship is unique in that we provide actionable intelligence, not just raw data. Our experienced analytics experts work with you to explain how the data impacts your drug development, and to establish the appropriate reporting procedures to give you what you need when you need it. Starting with your biomarker(s) and disease efficacy hypothesis, we create a data profile for each tissue sample. We then curate and process the data into decision-enabling results. Simply put, it’s better data, put to better use.